Valuation: WEED, Inc.

Market Cap 4.2M 3.63M 3.41M 3.1M 5.84M 403M 5.92M 40.05M 15.7M 201M 15.77M 15.43M 671M P/E 2024
-7.8x
P/E 2025 -4.28x
Enterprise Value 4.69M 4.05M 3.81M 3.46M 6.51M 449M 6.61M 44.67M 17.51M 225M 17.59M 17.21M 748M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
40.53%
Yield 2024 *
-
Yield 2025 -
1 day+3.25%
1 week+6.99%
Current month+18.73%
1 month+9.89%
3 months+1.80%
6 months-12.89%
Current year-34.55%
1 week 0.02
Extreme 0.02448
0.03
1 month 0.02
Extreme 0.022
0.03
Current year 0.02
Extreme 0.0159
0.05
1 year 0.02
Extreme 0.0159
0.08
3 years 0.02
Extreme 0.0159
0.15
5 years 0.02
Extreme 0.0159
0.49
10 years 0.02
Extreme 0.0159
15.2
Manager TitleAgeSince
Chief Executive Officer 73 2014-09-29
Corporate Secretary 49 2014-09-29
Director TitleAgeSince
Director/Board Member 49 2004-12-31
Director/Board Member 73 2004-12-31
Date Insider Type Main position Quantity % Market Cap.
2/24/26 Sell

Director

240,605 0.1770%
5/6/22 Sell

Director

30,000 0.0248%
4/26/22 Sell

Director

20,000 0.0169%
Change 5-day change 1-year change 3-year change Capi.($)
+3.25%+6.99%-37.49%-63.25% 4.2M
-0.27%-0.81%+0.25%+19.51% 48.63B
+1.89%+5.08%+492.59%+629.24% 46.3B
+1.83%+2.75%+15.61%+91.22% 41.97B
-0.50%-1.56%+24.67%+12.17% 39.51B
-2.74%-7.13%+18.72%+49.04% 31.75B
-1.14%-2.51%+27.52%+136.42% 16.48B
+0.59%-2.25% - - 16.34B
-0.43%-0.34%+2.30%+29.02% 14B
-2.60%-1.00%+77.85%+40.37% 13.33B
Average -0.01%-0.09%+69.11%+104.86% 26.83B
Weighted average by Cap. -0.02%-0.35%+105.43%+155.34%

Financials

2024 2025
Net sales - -
Net income -511K -441K -415K -377K -709K -48.93M -720K -4.87M -1.91M -24.47M -1.92M -1.88M -81.52M -1.37M -1.19M -1.12M -1.01M -1.91M -131M -1.93M -13.08M -5.13M -65.76M -5.15M -5.04M -219M
Net Debt 292K 252K 237K 216K 406K 27.99M 412K 2.78M 1.09M 14M 1.1M 1.07M 46.63M 485K 419K 394K 358K 674K 46.47M 684K 4.62M 1.81M 23.24M 1.82M 1.78M 77.41M
Logo WEED, Inc.
WEED, Inc. is engaged in the business involving the purchase of land and building commercial grade cultivation centers to consult, assist, manage and lease to licensed dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.
Employees
2
Date Price Change Volume
26-08-18 US$0.0283 +3.25% 199,781
26-08-17 US$0.0274 -0.03% 10,115
26-08-14 US$0.0274 +3.37% 9,825
26-08-13 US$0.0266 -11.50% 93,468
26-08-12 US$0.0300 +13.42% 34,413
  1. Stock Market
  2. Stocks
  3. BUDZ Stock